These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 22100281
1. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii. Kempf M, Djouhri-Bouktab L, Brunel JM, Raoult D, Rolain JM. Int J Antimicrob Agents; 2012 Feb; 39(2):180-1. PubMed ID: 22100281 [No Abstract] [Full Text] [Related]
2. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units. Ozbek B, Otük G. Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868 [No Abstract] [Full Text] [Related]
3. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. Liang-Yu C, Kuo SC, Liu CY, Luo BS, Huang LJ, Lee YT, Chen CP, Chen TL, Fung CP. J Microbiol Immunol Infect; 2011 Oct; 44(5):358-63. PubMed ID: 21524973 [Abstract] [Full Text] [Related]
4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ. J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [Abstract] [Full Text] [Related]
5. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii. Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V. J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760 [Abstract] [Full Text] [Related]
6. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I, Zer Y, Bosnak VK, Mete AO, Namiduru M. J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [Abstract] [Full Text] [Related]
8. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Tripodi MF, Durante-Mangoni E, Fortunato R, Utili R, Zarrilli R. Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050 [Abstract] [Full Text] [Related]
9. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii. Ozbek B, Sentürk A. Chemotherapy; 2010 Dec; 56(6):466-71. PubMed ID: 21088399 [Abstract] [Full Text] [Related]
10. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method. Thamlikitkul V, Tiengrim S. J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574 [Abstract] [Full Text] [Related]
11. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W, Cui J, Liang B, Cai Y, Bai N, Cai X, Wang R. J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963 [Abstract] [Full Text] [Related]
13. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L. J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805 [Abstract] [Full Text] [Related]
14. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. Tan TY, Ng LS, Tan E, Huang G. J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671 [Abstract] [Full Text] [Related]
15. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii. Bian X, Liu X, Feng M, Bergen PJ, Li J, Chen Y, Zheng H, Song S, Zhang J. Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235 [Abstract] [Full Text] [Related]